Journals LibraryNHS NIHR - National Institute for Health Research
Horizon Scanning Research and Intelligence Centre
The NIHR Horizon Scanning Research & Intelligence Centre (NIHR HSRIC) aims to supply timely information to key policy- and decision-makers and research funders within the English NHS about emerging health technologies that may have a significant impact on patients or the provision of health services in the near future. See www.hsric.nihr.ac.uk
Technologies include emerging pharmaceuticals and advanced therapy medicinal products (ATMP), therapeutic vaccines, medical devices and equipment, diagnostic and predictive tests and procedures, rehabilitation aids and therapy, and public health activities. The NIHR HSRIC does not identify prophylactic vaccines (e.g. childhood vaccinations), new screening programmes, or new food products with claimed health benefits.
The NIHR HSRIC’s principal technology-based outputs are technology briefings and alerts that provide information on a single technology. In addition the Centre produces horizon scanning reviews. These aim to identify all new and emerging health technologies being developed within a specified time-frame, in a technology area, across a disease area or at a specific point on a patient pathway. They are often in response to a user request to inform commissioning and planning decisions, identify current UK research activity or identify the need for further research. The reviews can incorporate patient, expert and company feedback on the technologies that are identified using a bespoke identification strategy.
The horizon scanning reviews that are linked below are reviewed by an advisory group and an internal team (including a medical advisor) at HSRIC before they are published on the HSRIC website. The advisory group are involved throughout the development of the review and depending on the subject area can comprise clinical experts, technology experts and patients representatives.